146 filings
Page 4 of 8
8-K/A
oc1huxxnm4gm8xp awx
30 Dec 19
Entry into a Material Definitive Agreement
6:05am
8-K/A
r457yc3ould r7n
30 Dec 19
Other Events
6:02am
8-K
tt8ad3n16 mfuhxoiu
20 Dec 19
Ekso Bionics Announces $5.0 Million Registered Direct Offering
4:06pm
8-K
74upgy6aui8c3 7w03go
12 Nov 19
Departure of Directors or Certain Officers
4:20pm
8-K
ary4m
30 Oct 19
Ekso Bionics Reports Third Quarter 2019 Results
4:13pm
8-K
5hj6qv52
28 Oct 19
Entry into a Material Definitive Agreement
2:49pm
8-K
acxr mjaz
20 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:29pm
8-K
2oyfe84j0zcjmtaam3kc
1 Aug 19
Ekso Bionics Reports Second Quarter 2019 Results
4:11pm
8-K
59npuhvk
26 Jun 19
Departure of Directors or Certain Officers
4:05pm
8-K
hem8cd
24 May 19
Entry into a Material Definitive Agreement
9:31am
8-K
h00rk
6 May 19
Ekso Bionics Announces Appointment of Bill Shaw as Chief Commercial Officer
8:10am
8-K
4ld5olr029 liipx
1 May 19
Ekso Bionics Reports First Quarter 2019 Results
4:15pm
8-K
cn5jqi1 gk12vyv
11 Mar 19
Form of Amendment to Purchase Agreement
4:31pm
8-K
3ly52u35yhu6gudb6rvg
28 Feb 19
Ekso Bionics Reports Fourth Quarter and Year End 2018 Results
4:33pm
8-K
0cnueeva
30 Jan 19
Ekso Bionics Announces $100 Million Joint Venture to Develop the Exoskeleton Market in Asia
8:50am
8-K/A
vxkq ujfp
18 Jan 19
Other Events
12:00am
8-K
6x28 57tn9i
8 Jan 19
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results
8:30am
8-K
ayv8owwb tqeka4y
17 Dec 18
Separation Agreement and Full Release of All Claims
4:11pm
8-K
uwhw3pj
7 Nov 18
Ekso Bionics Reports Third Quarter 2018 Results
4:19pm
8-K
oud5495
5 Nov 18
Departure of Directors or Certain Officers
8:32am